UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 40

Sortiert nach

Ambulatory motor assessment in Parkinson's disease

Movement disorders, 2006-01, Vol.21 (1), p.34-44

2006

Volltextzugriff (PDF)

Comparison of a timed motor test battery to the Unified Parkinson's Disease Rating Scale-III in Parkinson's disease

Movement disorders, 2008-09, Vol.23 (12), p.1707-1717

2008

Volltextzugriff (PDF)

Paramedical treatment in primary dystonia: A systematic review

Movement disorders, 2009-11, Vol.24 (15), p.2187-2198

2009

Volltextzugriff (PDF)

Cerebrospinal fluid analysis differentiates multiple system atrophy from Parkinson's disease

Movement disorders, 2004-05, Vol.19 (5), p.571-579

2004

Volltextzugriff (PDF)

Gender differences in Parkinson’s disease

Journal of neurology, neurosurgery and psychiatry, 2007-08, Vol.78 (8), p.819-824

2007

Volltextzugriff (PDF)

Movement parameters that distinguish between voluntary movements and levodopa-induced dyskinesia in Parkinson’s disease

Human movement science, 2003-02, Vol.22 (1), p.67-89

2003

Volltextzugriff (PDF)

The Symptom Checklist-90 Revised Questionnaire: No Psychological Profiles in Complex Regional Pain Syndrome–Dystonia

Journal of pain and symptom management, 1999-05, Vol.17 (5), p.357-362

1999

Volltextzugriff (PDF)

How much phenotypic variation can be attributed to parkin genotype?

Annals of neurology, 2003-08, Vol.54 (2), p.176-185

2003

Volltextzugriff (PDF)

Timed motor tests can detect subtle motor dysfunction in early Parkinson's disease

Movement disorders, 2010-07, Vol.25 (9), p.1150-1156

2010

Volltextzugriff (PDF)

Executive functions and disease characteristics in Parkinson's disease

Neuropsychologia, 1996-07, Vol.34 (7), p.617-626

1996

Volltextzugriff (PDF)

Estrogen as neuroprotectant of nigrostriatal dopaminergic system: laboratory and clinical studies

Endocrine, 2003-06, Vol.21 (1), p.67-76

2003

Volltextzugriff (PDF)

Pallidopyramidal disease: A misnomer?

Movement disorders, 2010-07, Vol.25 (9), p.1109-1115

2010

Volltextzugriff (PDF)

Automatic assessment of levodopa-induced dyskinesias in daily life by neural networks

Movement disorders, 2003-01, Vol.18 (1), p.70-80

2003

Volltextzugriff (PDF)

Risk of Disabling Response Fluctuations and Dyskinesias for Dopamine Agonists Versus Levodopa in Parkinson's Disease

Journal of Parkinson's disease, 2015-01, Vol.5 (4), p.847

2015

Volltextzugriff (PDF)

Symptoms and duration of the prodromal phase in parkinson's disease

Movement disorders, 1997-11, Vol.12 (6), p.871-876

1997

Volltextzugriff (PDF)

Intermediate CAG repeat lengths (53,54) for MJD/SCA3 are associated with an abnormal phenotype

Annals of neurology, 2001-06, Vol.49 (6), p.805-808

2001

Volltextzugriff (PDF)

Cerebrospinal fluid Aβ42 levels in multiple system atrophy

Movement disorders, 2004-02, Vol.19 (2), p.238-240

2004

Volltextzugriff (PDF)

Motor cortex activation in Parkinson's disease: Dissociation of electrocortical and peripheral measures of response generation

Movement disorders, 1999-09, Vol.14 (5), p.790-799

1999

Volltextzugriff (PDF)

About the anti-Parkinson equivalency of levodopa and dopamine agonists

Clinical neuropharmacology, 2007-01, Vol.30 (1), p.60-62

2007

Volltextzugriff (PDF)

Movement disorder of the lower lip

Movement disorders, 2005-08, Vol.20 (8), p.1085-1086

2005

Volltextzugriff (PDF)

Striatal dopamine and learning strategy-an (123)I-FP-CIT SPECT study

Neuropsychologia, 2004, Vol.42 (8), p.1071-1078

2004

Volltextzugriff (PDF)

Improvement of voicing in patients with Parkinson's disease by speech therapy

Neurology, 2003-11, Vol.61 (9), p.1316; author reply 1316

2003

Volltextzugriff (PDF)

Striatal dopamine and learning strategy—an [formula omitted]-FP-CIT SPECT study

Neuropsychologia, 2004, Vol.42 (8), p.1071-1078

2004

Volltextzugriff (PDF)

Cerebrospinal fluid Aβ 42 levels in multiple system atrophy

Movement disorders, 2004-02, Vol.19 (2), p.238-240

2004

Volltextzugriff (PDF)

Memory and learning strategies in patients with Parkinson's disease

Neuropsychologia, 1994-03, Vol.32 (3), p.335-342

1994

Volltextzugriff (PDF)

1 – 25 von 40

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(38)
Mit Volltextzugriff
(36)

Publikationsform

Artikel
(40)

Sprache

Englisch
(40)
Japanisch
(5)

Erscheinungsjahr

n.n

Thema

Humans
(33)
Life Sciences & Biomedicine
(31)
Science & Technology
(31)
Neurosciences & Neurology
(27)
Female
(26)
Male
(23)
Clinical Neurology
(22)
Middle Aged
(22)
Biological And Medical Sciences
(20)
Medical Sciences
(20)
Aged
(16)
Neurology
(15)
Parkinson's Disease
(14)
Adult
(13)
Parkinson Disease - Physiopathology
(11)
Neurosciences
(9)
Parkinson Disease - Diagnosis
(8)
Parkinson Disease - Drug Therapy
(8)
Psychology
(8)
Social Sciences
(7)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Ambulatory motor assessment in Parkinson's disease

Comparison of a timed motor test battery to the Unified Parkinson's Disease Rating Scale-III in Parkinson's disease

Paramedical treatment in primary dystonia: A systematic review

Cerebrospinal fluid analysis differentiates multiple system atrophy from Parkinson's disease

Gender differences in Parkinson’s disease

Movement parameters that distinguish between voluntary movements and levodopa-induced dyskinesia in Parkinson’s disease

The Symptom Checklist-90 Revised Questionnaire: No Psychological Profiles in Complex Regional Pain Syndrome–Dystonia

How much phenotypic variation can be attributed to parkin genotype?

Timed motor tests can detect subtle motor dysfunction in early Parkinson's disease

Executive functions and disease characteristics in Parkinson's disease

Estrogen as neuroprotectant of nigrostriatal dopaminergic system: laboratory and clinical studies

Pallidopyramidal disease: A misnomer?

Automatic assessment of levodopa-induced dyskinesias in daily life by neural networks

Risk of Disabling Response Fluctuations and Dyskinesias for Dopamine Agonists Versus Levodopa in Parkinson's Disease

Symptoms and duration of the prodromal phase in parkinson's disease

Intermediate CAG repeat lengths (53,54) for MJD/SCA3 are associated with an abnormal phenotype

Cerebrospinal fluid Aβ42 levels in multiple system atrophy

Motor cortex activation in Parkinson's disease: Dissociation of electrocortical and peripheral measures of response generation

About the anti-Parkinson equivalency of levodopa and dopamine agonists

Movement disorder of the lower lip

Striatal dopamine and learning strategy-an (123)I-FP-CIT SPECT study

Improvement of voicing in patients with Parkinson's disease by speech therapy

Striatal dopamine and learning strategy—an [formula omitted]-FP-CIT SPECT study

Cerebrospinal fluid Aβ 42 levels in multiple system atrophy

Memory and learning strategies in patients with Parkinson's disease

Suchergebnisse filtern